LobbyingOak Street Health lobbying by quarter
Oak Street Health's latest lobbying report covers Q2 2023, at $240K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Oak Street Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $232K | 1 |
| Q1 2023 | $236K | 1 |
| Q2 2023 | $240K | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$354K · 3 reports
- Medicare and Medicaid$354K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)3 reports
- HOUSE OF REPRESENTATIVES3 reports
- SENATE3 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseOak Street Health | $708K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/07/19for Q2 2023 | In-house | $240K |
| 23/07/19for Q2 2023 | In-house | $240K |
| 23/04/17for Q1 2023 | In-house | $236K |
| 23/01/06for Q4 2022 | In-house | $232K |